Tumor Infiltrating Lymphocytes – The Next Step in Assessing Outcome and Response to Treatment in Patients with Breast Cancer

por Wesolowski, Robert, Carson, William E
Publicado 2014

Observations on the use of Bruton’s tyrosine kinase inhibitors in SAR-CoV-2 and cancer

por Benner, Brooke, Carson, William E.
Publicado 2021

Analysis of potential biomarkers of response to IL‐12 therapy

por Schwarz, Emily, Carson, William E.
Publicado 2022

Biphasic anaphylactic reaction to blue dye during sentinel lymph node biopsy

por Liang, Margaret I, Carson, William E
Publicado 2008

Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer

por Wesolowski, Robert, Markowitz, Joseph, Carson, William E
Publicado 2013

Bruton’s tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironment

por Good, Logan, Benner, Brooke, Carson, William E.
Publicado 2021

NK cell-based immunotherapy for treating cancer: will it be promising?

por Cho, Duck, Kim, Sang-ki, Carson, William E.
Publicado 2011

Concurrent phyllodes tumor, eccrine carcinoma, and multinodular goiter 20 years after radiotherapy for Hodgkin lymphoma

por Quinn, Kristen M., Tozbikian, Gary, Carson, William E.
Publicado 2018

Unusual recurrence of breast cancer in a BRCA‐variant patient after fat grafting

por Skendelas, John P., Lee, Clara, Mangino, Ann, Carson, William E.
Publicado 2018

Ulcerated Cutaneous Melanoma: A Review of the Clinical, Histologic, and Molecular Features Associated with a Clinically Aggressive Histologic Phenotype

por Barricklow, Zoe, DiVincenzo, Mallory J, Angell, Colin D, Carson, William E
Publicado 2022

Tissue factor-targeted immunotherapy of melanoma and triple negative breast cancer using a second generation ICON

por Hu, Zhiwei, McMichael, Elizabeth, Campbell, Amanda, London, Cheryl A, Carson, William E
Publicado 2015

Sentinel node mapping and biopsy in ectopic axillary breast cancer: A case report and review of the literature

por Harris, Micah K., Guo, Marissa Z., Mangino, Ann, Taylor, Clayton, Carson, William E.
Publicado 2022

Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo

por Foy, Kevin C., Miller, Megan J., Moldovan, Nicanor, Carson, William E., Kaumaya, Pravin T. P.
Publicado 2012

Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti...

por Foy, Kevin C., Miller, Megan J., Moldovan, Nicanor, Carson, William E., Kaumaya, Pravin P.T.
Publicado 2013

Study of circulating myeloid derived suppressor cells (MDSC) in patients with breast cancer undergoing neo-adjuvant chemotherapy; interim results

por Wesolowski, Robert, Markowitz, Joseph, Paul, Bonnie, Carothers, Sarah, Abdel-Rasoul, Mahmoud, Carson, William E
Publicado 2013

Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ova...

por Hu, Zhiwei, Xu, Jie, Cheng, Jijun, McMichael, Elizabeth, Yu, Lianbo, Carson, William E.
Publicado 2016

CD200 Blockade Modulates Tumor Immune Microenvironment but Fails to Show Efficacy in Inhibiting Tumor Growth in a Murine Model of Melanoma

por Talebian, Fatemeh, Yu, Jianyu, Lynch, Kimberly, Liu, Jin-Qing, Carson, William E., Bai, Xue-Feng
Publicado 2021

Immunotherapy with HER-2 and VEGF peptide mimics plus metronomic paclitaxel causes superior antineoplastic effects in transplantable and transgenic mouse models of human breast can...

por Foy, Kevin C., Miller, Megan J., Moldovan, Nicanor, Bozanovic, Tatjana, Carson, William E., Kaumaya, Pravin T. P.
Publicado 2012

Interleukin-21 activates natural killer cell activity against cetuximab-coated pancreatic tumor cells

por McMichael, Elizabeth L, Jaime-Ramirez, Alena Cristin, Guenterberg, Kristan, Luedke, Eric, Atwal, Lakhvir, Carson, William E
Publicado 2015

Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology

por Shu, Dan, Li, Hui, Shu, Yi, Xiong, Gaofeng, Carson, William E., Haque, Farzin, Xu, Ren, Guo, Peixuan
Publicado 2015